Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, Recursion announced positive Phase 1b/2 results for REC-4881, which is its ...
A photo is circulating on social media that appears to show President Donald Trump using a walker, but it is AI-generated. The image was originally posted on X by Democratic strategist Keith Edwards, ...
Dec 11 (Reuters) - Walt Disney (DIS.N), opens new tab is investing $1 billion in OpenAI and will let the startup use characters from Star Wars, Pixar and Marvel franchises in its Sora AI video ...
CLEVELAND, Ohio — One in eight adults in the United States are now using Ozempic, Wegovy or similar GLP-1 drugs, according to a new KFF Health Tracking Poll. The poll also found that cost and side ...
Necrobotics is a field of engineering that builds robots out of a mix of synthetic materials and animal body parts. It has produced micro-grippers with pneumatically operated legs taken from dead ...
A black fan exposes a Alabama Crimson Tide fan for calling him racial slurs. No. 10-ranked Alabama Crimson Tide took down the Eastern Illinois University Panthers 56-0 on Senior Day. The game was ...
A historic Jersey City printing facility that once churned out copies of the New York Daily News is being transformed into a modern logistics complex. Plans call for the completion of the complex by ...
A severed mosquito proboscis can be turned into an extremely fine nozzle for 3D printing, and this could help create replacement tissues and organs for transplants. Changhong Cao at McGill University ...
Apple Intelligence has gotten a bad rap compared with Google Gemini and other AI options, but I'm using some features on a daily basis. Jeff Carlson writes about mobile technology for CNET. He is also ...
President Donald Trump boarded Air Force One quickly using the small stairs due to "increased security measures" at Palm Beach International Airport on Sunday, a White House official tells Fox News.
In the phase 3 EMBARK trial, enzalutamide plus leuprolide and enzalutamide monotherapy were associated with longer metastasis-free survival than leuprolide alone among patients with biochemically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results